Immunisation against a serine protease inhibitor reduces intensity of Plasmodium berghei infection in mosquitoes.
Williams AR., Zakutansky SE., Miura K., Dicks MDJ., Churcher TS., Jewell KE., Vaughan AM., Turner AV., Kapulu MC., Michel K., Long CA., Sinden RE., Hill AVS., Draper SJ., Biswas S.
The mosquito innate immune response is able to clear the majority of Plasmodium parasites. This immune clearance is controlled by a number of regulatory molecules including serine protease inhibitors (serpins). To determine whether such molecules could represent a novel target for a malaria transmission-blocking vaccine, we vaccinated mice with Anopheles gambiae serpin-2. Antibodies against Anopheles gambiae serpin-2 significantly reduced the infection of a heterologous Anopheles species (Anopheles stephensi) by Plasmodium berghei, however this effect was not observed with Plasmodium falciparum. Therefore, this approach of targeting regulatory molecules of the mosquito immune system may represent a novel approach to transmission-blocking malaria vaccines.